Amansa Investments Backs Rubicon Research with Rs 250 Crore Pre-IPO Boost
Published on: Aug. 14, 2025, 12:14 p.m. | Source: Devdiscourse
Amansa Investments Ltd has infused Rs 250 crore into Rubicon Research Ltd, a prominent pharma formulation company, through a pre-IPO funding round. This investment alters General Atlantic's equity holding from 57.57% to 54.01%. Aiming at strategic growth and debt repayment, Rubicon adjusts its IPO plans.
